Modélisation et essais cliniques en pédiatrie
Authors:
- D. ArmengaudDAD. Armengaud
- I. BostIBI. Bost
- A. CarpentierACA. Carpentier
- C. CaulinCCC. Caulin
- C. CrépinCCC. Crépin
- E.-M. FuseauEFE.-M. Fuseau
- M. GerbergMGM. Gerberg
- C. GrosskopfCGC. Grosskopf
- C. LaveilleCLC. Laveille
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in childrenToxicology, 2003
- The history of thalidomideDrug News & Perspectives, 2002
- Incidence of adverse drug reactions in paediatric in/out‐patients: a systematic review and meta‐analysis of prospective studiesBritish Journal of Clinical Pharmacology, 2001
- Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosisBritish Journal of Clinical Pharmacology, 2001
- Off label and unlicensed drug use among French office based paediatriciansArchives of Disease in Childhood, 2000
- Les préparations pédiatriques dans les hôpitaux françaisArchives de Pédiatrie, 2000
- Database could give children safer medicinesNature, 2000
- Pharmacokinetic/Pharmacodynamic Modeling in Drug DevelopmentAnnual Review of Pharmacology and Toxicology, 2000
- Survey of unlicensed and off label drug use in paediatric wards in European countriesBMJ, 2000
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998